BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18826517)

  • 1. Melanoma associated spongiform scleropathy: characterization, biochemical and immunohistochemical studies.
    Alyahya GA
    Acta Ophthalmol; 2008 Oct; 86 Thesis 3():1-21. PubMed ID: 18826517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-2 is expressed in melanoma-associated spongiform scleropathy.
    Alyahya GA; Kolko M; Prause JU; Nielsen BS; Wang J; Heegaard S
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2806-11. PubMed ID: 18579756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma-associated spongiform scleropathy: biochemical changes and possible relation to tumour extension.
    Alyahya GA; Ribel-Madsen SM; Heegaard S; Prause JU; Trier K
    Acta Ophthalmol Scand; 2003 Dec; 81(6):625-9. PubMed ID: 14641266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of melanoma associated spongiform scleropathy.
    Alyahya GA; Heegaard S; Prause JU
    Acta Ophthalmol Scand; 2002 Jun; 80(3):322-6. PubMed ID: 12059874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D
    Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Acta Ophthalmol; 2012 Jun; 90(4):341-9. PubMed ID: 20809904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
    Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
    J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
    Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
    Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI for the evaluation of scleral invasion and extrascleral extension of uveal melanomas.
    Récsán Z; Karlinger K; Fodor M; Zalatnai A; Papp M; Salacz G
    Clin Radiol; 2002 May; 57(5):371-6. PubMed ID: 12014934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
    Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
    Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation.
    Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S
    Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rationale for implant insertion after enucleation of eyes with uveal melanoma].
    Stoiukhina AS
    Vestn Oftalmol; 2011; 127(1):29-32. PubMed ID: 21539101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scleral patch grafts in the management of uveal and ocular surface tumors.
    Barman M; Finger PT; Milman T
    Ophthalmology; 2012 Dec; 119(12):2631-6. PubMed ID: 22858126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Block resection with scleral flap rotation in ciliary body melanoma].
    Romanowska-Dixon B
    Klin Oczna; 2005; 107(10-12):681-3. PubMed ID: 16619819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
    Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
    Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.